Diagnostic, prognostic and therapeutic potential of 6-minute walk test in patients with heart failure
A. V. Budnevsky,
A. Ya. Kravchenko,
R. E. Tokmachev,
T. A. Chernik,
E. V. Tokmachev,
Yu. B. Letnikova https://doi.org/10.15829/1728-8800-2020-2460
Abstract
The six-minute walk test (6MWT) is a well-known exercise test used in medical practice to assess the functional status of patients with various chronic cardiovascular and respiratory diseases. The results of modern research describe new potential of 6MWT, which allow a more accurate interpretation and predict the course of diseases. Heart failure (HF) is the outcome of many structural and functional heart disorders. To improve the prognosis of patients with HF, early diagnosis, appropriate therapy and effective control of the disease course are important components. This review describes the diagnostic, prognostic and therapeutic potential of 6MWT in patients with HF.
About the Authors
A. V. Budnevsky
ФГБОУ ВО Воронежский государственный медицинский университет им. Н. Н. Бурденко Минздрава России
Russian Federation
Russian Federation
A. Ya. Kravchenko
N. N. Burdenko Voronezh State Medical University
Russian Federation
Voronezh
Russian Federation
Voronezh
R. E. Tokmachev
N. N. Burdenko Voronezh State Medical University
Russian Federation
Voronezh
Russian Federation
Voronezh
T. A. Chernik
N. N. Burdenko Voronezh State Medical University
Russian Federation
Voronezh
Russian Federation
Voronezh
E. V. Tokmachev
N. N. Burdenko Voronezh State Medical University
Russian Federation
Voronezh
Russian Federation
Voronezh
Yu. B. Letnikova
N. N. Burdenko Voronezh State Medical University
Russian Federation
Voronezh
Russian Federation
Voronezh
References
1. Ponikowski PA. Voors AD. Anker S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;(1):7-81. (In Russ.) doi:10.15829/1560-4071-2017-1-7-81.
2. Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russ J Cardiol. 2016;6:7-13. (In Russ.) doi:10.15829/1560-4071-2016-8-7-13.
3. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics — 2013 update: a report from the American Heart Association. Circulation. Author manuscript. 2013;127(1):e6-e245. doi:10.1161/CIR.0b013e31828124ad.
4. Tripoliti EE, Papadopoulos TG, Karanasiou GS, et al. Heart Failure: Diagnosis, Severity, Estimation and Prediction of Adverse Events through Machine Learning Techniques. Computational and Structural Biotechnology Journal. 2017;15:26-47. doi:10.1016/j.csbj.2016.11.001.
5. Inamdar AA, Inamdar AC. Heart Failure: Diagnosis, Management and Utilization. J Clin Med. 2016;5(7):62. doi:10.3390/jcm5070062.
6. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1):185-209. doi:10.1183/09031936.00046906.
7. Sidorenko GI, Frolov AV, Komissarova SM. Diagnosis of heart failure (new quantitative approaches). Cardiology in Belarus. 2009;4(05):24-8. (In Russ.)
8. Tkachenko OV, Serik SA. Six-minute walk test results in patients with heart failure due to coronary heart disease. Ukrainskiy terapevticheskiy zhurnal. (In Russ.) 2015;4:14-9.
9. Lindemberg S, Chermont S, Quintão M, et al. Heart rate recovery in the first minute at the six-minute walk test in patients with heart failure. Arq Bras Cardiol. 2014;102(3):279-87. doi:10.5935/abc.20140036.
10. Rubim VS, Drumond NC, Romeo JL, et al. Prognostic value of the Six-Minute Walk Test in heart failure. Arq Bras Cardiol. 2006;86(2):120-5. doi:10.1590/s0066-782x2006000200007.
11. Abraham WT, Adamson PB, Bourge RC. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658-66. doi:10.1016/S0140-6736(11)60101-3.
12. Brooks GC, Vittinghoff E, Iyer S. Accuracy and usability of a self-administered 6-minute walk test smartphone application. Circ Heart Fail. 2015;8(5):905-13. doi:10.1161/CIRCHEARTFAILURE.115.002062.
13. Ferreira JP, Metra M, Anker SD. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2019;21(2):218-26. doi:10.1002/ejhf.1380.
14. Enright PL. The six-minute walk test. Respir Care. 2003;48(8):783-5.
15. Du H, Newton PJ, Salamonson Y, Carrieri-Kohlman VL, et al. A review of the six-minute walk test: its implication as a self-administered assessment tool. Eur J Cardiovasc Nurs. 2009;8(1):2-8. doi:10.1016/j.ejcnurse.2008.07.001.
16. Chan KS, Pfoh ER, Denehy L, et al. Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure. Chest. 2015;147(5):1316-26. doi:10.1378/chest.14-1808.
17. Barbosa R, Pagotti M, Paula T, et al. Impact of heart failure clinic on six-minute walk test. Int J Cardiovasc Sci. 2015;28(6):451-9. doi:10.5935/2359-4802.20150065.
18. Shoemaker MJ, Curtis AB, Vangsnes E, et al. Triangulating clinically meaningful change in the six-minute walk test in individuals with chronic heart failure: a systematic review. Cardiopulm Phys Ther J. 2012;23(3):5-15.
19. Ingle L, Cleland JG, Clark AL. The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Ann Phys Rehabil Med. 2014;57(4):244-53. doi:10.1016/j.rehab.2014.03.004.
20. Wegrzynowska-Teodorczyk K, Rudzinska E, Lazorczyk M, et al. Distance covered during a six-minute walk test predicts longterm cardiovascular mortality and hospitalisation rates in men with systolic heart failure: an observational study. J Physiother. 2013;59(3):177-87. doi:10.1016/S1836-9553(13)70182-6.
21. Stewart RA, Szalewska D, She L, et al. Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail. 2014;2(4):335-43. doi:10.1016/j.jchf.2014.02.009.
22. Shubitidze I. Z., Tregubov V. G., Kanorskii S. G., Pokrovsky V. M. Regulatory-adaptive state in evaluation of bisoprolol and nebivolol therapy effectiveness for ventricular arrhythmia. Cardiovascular Therapy and Prevention. 2016;15(6):24-30. (In Russ.) doi:10.15829/1728-8800-2016-6-24-30.
23. Dereglazova YuA, Zhebeleva YuA. Comparative effectiveness of the standard and modified 6-minute walk test with on-line monitoring of heart rate in assessing the severity of chronic heart failure. Science and world. 2013;3(3):230-23. (In Russ.)
24. Ingle L, Shelton RJ, Rigby AS, et al. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J. 2005;26(17):1742-51. doi:10.1093/eurheartj/ehi259.
25. Toukhsati SR, Mathews S, Sheed A, et al. Confirming a beneficial effect of the six-minute walk test on exercise confidence in patients with heart failure. Eur J Cardiovasc Nurs. 2019;1(7):165-71. doi:10.1177/1474515119876784.
26. Ha FJ, Toukhsati SR, Cameron JD, et al. Association between the 6-Minute Walk Test and exercise confidence in patients with heart failure: A prospective observational study. Heart Lung. 2018;47(1):54-60. doi:10.1016/j.hrtlng.2017.09.006.
27. Mustafina MKh, Chernyak AV. Cardiorespiratory stress test. Practical pulmonology. 2013;3:56-62. (In Russ.) Мустафина М. Х., Черняк А. В. Кардиореспираторный нагрузочный тест. Практическая пульмонология. 2013;3:56-62.
28. Forman DE, Fleg JL, Kitzman DW, et al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol. 2012;60(25):2653-61. doi:10.1016/j.jacc.2012.08.1010.
29. Pollentier B, Irons SL, Benedetto CM, et al. Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J. 2010;21(1):13-21.
30. Kervio G, Ville NS, Leclercq C, et al. Intensity and daily reliability of the six-minute walk test in moderate chronic heart failure patients. Arch Phys Med Rehabil. 2004;85(9):1513-8. doi:10.1016/j.apmr.2003.09.035.
31. Ciani O, Piepoli M, Smart N, et al. Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials. JACC Heart Fail. 2018;6(7):596-604. doi:10.1016/j.jchf.2018.03.017.
32. Howie-Esquivel J, Dracup K. Does oxygen saturation or distance walked predict rehospitalization in heart failure? J Cardiovasc Nurs. 2008;23(4):349-56. doi:10.1097/01. JCN.0000317434.29339.14.
Supplementary files
Review
For citations:
Budnevsky A.V., Kravchenko A.Ya., Tokmachev R.E., Chernik T.A., Tokmachev E.V., Letnikova Yu.B. Diagnostic, prognostic and therapeutic potential of 6-minute walk test in patients with heart failure. Cardiovascular Therapy and Prevention. 2020;19(6):2460. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2460
Views:
2857
Email this article 
